Abstract:Most of polymeric vesicles not only lack the specific recognitions of immune cells and the bioactivities of adjuvants to trigger efficient adaptive immunities, but also lack good biodegradability and biocompatibility, which hamper the immunotherapy applications. To develop biodegradable polymer nano-carries with both immune activity and cell-targeting, three kinds of glycopolypeptide nanovesicles constructed by linear polypeptide-glycodendrimer copolymers were synthesized and the applications in co-delivery of protein antigens and agonists were studied. The glycopolypeptide nanovesicles (PNLys-4Man, PNLys-4Gal, PNLys-4Glu) were fabricated in aqueous solution by a dialysis method, which had similar sugar density, hydrodynamic size of about 100 nm and Zeta potential of about 35 mV, and present sugar-dependent recognition with lectins. Those glycopolypeptide vesicles could co-load ovalbumin (OVA) and imiquimote (R837) in phosphate buffer solution (pH=7.4) to give a hydrodynamic size of about 75 nm, and the loading capacity of OVA and R837 was about 7.5% and about 1.3%, respectively. Moreover, those vesicles showed sugar-dependent adjuvant effects of promoting dendritic cell (DCs) maturation, in which the mannosylated ones enhanced the maturation of DCs to 34.6% compared to the galactosylated ones of 29.4% and the glucosylated ones of 27.7%. These data evidence that the mannosylated glycopolypeptide vesicles exhibited a cell-targeting enhanced immunity. Furthermore, the mannosylated nanovesicles activated the maturation of DCs to secret costimulatory molecules of IL-6 and TNF-a, and their levels were respectively enhanced by 19.5% and 20.3% than the galactosylated ones, and by 17.7% and 37.4% than the glucosylated ones, further confirming the sugar- dependent maturation effect on DCs. Especially, UV light triggered intracellular rapid co-release of OVA and R837, and the levels of IL-6 and TNF-alpha remarkably enhanced by 2.19-fold and 1.82-fold, demonstrating that OVA antigen and R837 agonist possessed synergistic effect to promote DCs maturation and induce strong immune response. Consequently, this work opens a new avenue to construct the immune cells-targeted biodegradable nanocarriers for delivering antigens and agonists to fight against infectious diseases and cancers.

Supramolecular Glyco-Nanoparticles Toward Immunological Applications

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Facile Preparation of Cancer-Specific Polyelectrolyte Nanogels from Natural and Synthetic Sugar Polymers

A Computational and Chemical Design Strategy for Manipulating Glycan‐Protein Recognition

Covalent and Oriented Immobilization of Scfv Antibody Fragments Via an Engineered Glycan Moiety

Hydrogel-to-Nanoparticle Transition with Immune Cell Activation Controlled by Dual Supramolecular Interactions

Glycosylated Polypeptide Nanovesicles: Fabrication, Protein and Agonist Codelivery and Immune Activity

Silver Nanoparticle Plasmonic Enhanced Forster Resonance Energy Transfer (Fret) Imaging Of Protein-Specific Sialylation On The Cell Surface

DNA nanoprobes for detection and imaging of glycoproteins

Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy

Chemical Synthesis of Globo H and Mannobiose Glycopolymers and Their Immunological Stimulation

Biospecific Self‐Assembly of a Nanoparticle Coating for Targeted and Stimuli‐Responsive Drug Delivery

Nanogel: A Versatile Nano-Delivery System for Biomedical Applications

Expanding Structural Space for Immunomodulatory Nucleic Acid Nanoparticles (Nanps) via Spatial Arrangement of Their Therapeutic Moieties

Naphthalimide‐based Functional Glycopolymeric Nanoparticles as Fluorescent Probes for Selective Imaging of Tumor Cells

Glyconanoparticles for biomedical applications.

Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects

A Facile, Protein‐Derived Supramolecular Theranostic Strategy for Multimodal‐Imaging‐Guided Photodynamic and Photothermal Immunotherapy In Vivo

In Situ Formation of Au-Glycopolymer Nanoparticles for Surface-Enhanced Raman Scattering-Based Biosensing and Single-Cell Immunity

Polyvalent Glycomimetic-Gold Nanoparticle Conjugates reveal effects of glycan display on Multivalent Lectin-Glycan Interactions

Antibody-Free Glycogen Nanoparticles Engage Human Immune T Cells for Intracellular Delivery of Small Drugs or mRNA